Trafficking of hyaluronan in the interstitium and its possible implications

Lymphology

Volumn 37, Issue 1, 2004, Pages 6-14

  Liu, Ningfei ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PLASMA PROTEIN; WATER;

HUMAN; INTERSTITIUM; LYMPH FLOW; LYMPHATIC SYSTEM; LYMPHEDEMA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; HYALURONIC ACID; LYMPHATIC SYSTEM; LYMPHEDEMA;

EID: 1842482082     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Aukland, K, RK Reed: Interstitial lymphatic mechanisms in the control of entracellular fluid volume. Physiol. Rev. 73 (1993), 1-60.
2. Kundson, W, DJ Aguiar, Q Hua, et al: CD44-anchored hyaluronan-rich pericellular matrices: An ultrastructural and biochemical analysis. Exp. Cell Res. 228 (1996), 216-228.
3. Abatagelo, G, DH Weigel (Eds.): Redefining Hyaluronan. Elsevier Science Publishers B.V. Amsterdam, 2000.
4. Pillips, GO, JF Kennedy (Eds.): Hyaluronan 2000, Woodhead Publishing, Cambridge, United Kingdom, 2001.
5. Liu, NF, LR Zhang: Changes of tissue fluid hyaluronan (hyaluronic acid) in peripheral lymphedema. Lymphology 31 (1998), 173-179.
6. Liu, NF, L Shao, X Xu, et al: Hyaluronan metabolism in rat tail skin following blockage of the lymphatic circulation. Lymphology 35 (2002), 15-22.
7. Laurent, TC, JRE Fraser: The properties and turnover of the hyaluronan. In: Functions Of The Proteoglycans. Evered, D, J Whelan (Eds.), New York, Wiley, Ciba Foundation Symposium 124 (1986), 9-29.
8. Laurent, TC (Ed.): The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivates, Portland Press, London, Wenner-Gren International Series 72, 1998.
9. Fraser, JR, WG Kimpton, TG Laurent et al: Uptake and degradation of hyaluronan in lymphatic tissue. Biochem. J. 256 (1988), 153-158.
10. Fraser, JR, TC Laurent: Turnover and metabolism of hyaluronan. CIBA Foundation Symposium 143 (1989), 41-53.
11. Tammi, MI, AJ Day, EA Turley: Hyaluronan and homeostasis: A balancing act. J. Biol. Chem. 277 (2002), 4581-4584.
12. Prevo, K, S Banerji, DJP Ferguson: Mouse LYVE-1 in an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276 (2001), 19420-19430.
13. nd edition. New York: Plenum Press (1991), 305-341.
14. Prestwich, DAJ: Hyaluronan-binding proteins: Tying up the giant. J. Biol. Chem. 277 (2002), 4585-4588.
15. Kundson, CB, W Kundson: Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 7 (1993), 1233-1241.
16. Banerji, S, J Ni, SX Wang, et al: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801.
17. O'Morchoe, CC, PJ O'Morchoe: The renal lymphatic system. Contrib. Nephrol. 68 (1988), 230-237.
18. O'Morchoe, CC, WRD Jones, HM Jarosz, et al: Temperature dependence of protein transport across lymphatic endothelium in vitro. J. Cell Biol. 98 (1984), 629-640.
19. Lee, JY, AP Spicer: Hyaluronan: A multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell. Biol. 12 (2000), 581-5820.
20. Kaya, G, I Rodrignez, JL Jorcano, et al: Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promotor disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Gene & Develop. 11 (1997), 996-1007.
21. Aroffo, A, I Stamenkovic, M Melnick, et al: CD44 is the principal cell surface receptor for hyaluronate. Cell 61 (1990), 1303-1313.
22. Lesley, J, R Hyman, PW Kincade, et al: CD44 and its interaction with the extracellular matrix. Adv. Immunol. 54 (1994), 271-335.
23. Camenisch, TD, AP Spicer, T Brehm-Gibson, et al: Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106 (2000), 349-360.
24. McKee, CM, MB Penno, M Cownan, et al: Hyaluronan(HA) fragments induce chemokine gene expression in adveolar macrophages. J. Clin. Invest. 98 (1996), 2403-2413.
25. Noble, PW, CM McKee, M Cownan, et al: Hyaluronan fragments activate an NF-kB/I-kB autoregulation loop in murine macrophages. J. Clin. Invest. 91 (1996), 2368-2377.
26. West, DC, IN Hampson, F Arnold, et al: Angiogenesis induced by degradation products of hyaluronic acid. Science 228 (1985), 1324-1346.
27. Olszewski, WL: Lymphangitis. In: Lymph Stasis: Pathophysiology, Diagnosis And Treatment. Boca Raton, FL, CRC Press, Inc. (1991), 293-298.
28. Bates, DO, JR Levick, PS Mortimer: Changes in macromolecular composition of the interstitial fluid from swollen arms after breast cancer treatment and its implications. Clin. Sci. 86 (1993), 737-746.
29. Toole, BP, TN Wight, MI Tammi: Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 277 (2002), 4593-4596.
30. Laurent, TC, JRE Fraser: The properties and turnover of hyaluronan. In: Functions of the Proteoglycans. Evered D, J Whelan J (Eds.), Ciba Foundation Symposium 124 (1986), 9-29.
31. Reed, RK, UB Laurent: Turnover of hyaluronan in the microcirculation. Am Rev. Respir. Dis. 146 (1992), S37-39.
32. Price, FM, JR Levick, RM Mason: Glycosaminoglycan concentration in synovium and other tissues of rabbit knee in relation to synovial hydraulic resistance. J. Physiol. 495 (1996), 803-820.
33. Wang, T, HH Cheng, O Heimburger, et al: Hyaluronan decreases peritoneal fluid absorption: Effect of molecular weight and concentration of hyaluronan. Kidney Intl. 55 (1999), 667-673.
34. Fraser, JR, WR Kimpton, TC Laurent, et al: Uptake and degradation of hyaluronan in lymphatic tissue. Biol. Chem. J. 256 (1988), 153-158.
35. Engstrom-Laurent, A: Changes in hyaluronan concentration in tissue and body fluid in disease states. CIBA Foundation Symposium 143 (1989), 233-247.
36. Lebel, LL, B Smith, TC Risberg: Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. Am. J. Physiol. 256 (1989), 1524-1531.
37. Olszewski, WL: Clinical picture of lymphedema. In: Lymph Stasis: Pathophysiology, Diagnosis And Treatment. Boca Raton, FL, CRC Press, Inc. (1991), 347-377.
38. Laurent, TC, JR Fraser: Hyaluronan. FASEB J. 6 (1992), 2397-2404.
39. Siegelman, MH, HC Grendele, P Estess: Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leuko. Biol. 66 (1999), 315-321.
40. Rigby, S, MO Dailey: Traffic of L-selectin-negative T cells to sites of inflammation. Eur. J. Immunol. 30 (2000), 98-107.
41. Mohamadzadc, M, H Degrendele, H Arizpe, et al: Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J. Clin. Invest. 101 (1998), 97-108.
42. Lesley, J, R Hymen, N English, et al: CD44 in inflammation and metastasis. Glycoconj. J. 14 (1997), 611-622.
43. Jackson, DG, R Prevo, S Clasper, et al: LYVE-1, the lymphatic system and tumor-lymphangiogenesis. Trends in Immunol. 122 (2001), 317-321.
44. Mikecz, K, FR Brennan, JH Kim, et al: Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1 (1995), 558-563.
45. Pure, E, CA Cuff: A crucial role for CD44 in inflammation Trends. Mol. Med. 7 (2001), 213-221.
46. Laugier, JP, S Shuster, M Rosdy, et al: Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: Evidence that hyaluronidase can permeate the stratum corneum. Br. J. Dermatol 142 (2000), 226-233.
47. Földi, E, A Sauerwald, B Hennig: Effect of complex decongestive physiotherapy on gene expression for the inflammatory response in peripheral lymphedema. Lymphology 33 (2000), 19-23.
48. Yasuda, M, K Nakano, K Yasumto: CD44: Functional relevance to inflammation and malignancy. Histol. Histopathol. 17 (2002), 945-950.
49. Nehls, V, W, Hayen: Are hyaluronan receptor involved in the three-dimensional cell migration? Histol. Histopathol. 15 (2000), 629-636.
50. Ramsden, CA, A Bankier, TJ Brown, et al: A new disorder of hyaluronan metabolism associated with generalized folding and thickening of the skin. J. Ped. 136 (2000), 62-68.